Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 8;24(16):12555.
doi: 10.3390/ijms241612555.

The Role of Hydrogen Sulfide (H2S) in Epigenetic Regulation of Neurodegenerative Diseases: A Systematic Review

Affiliations

The Role of Hydrogen Sulfide (H2S) in Epigenetic Regulation of Neurodegenerative Diseases: A Systematic Review

Bombonica Gabriela Dogaru et al. Int J Mol Sci. .

Abstract

This review explores the emerging role of hydrogen sulfide (H2S) in modulating epigenetic mechanisms involved in neurodegenerative diseases. Accumulating evidence has begun to elucidate the multifaceted ways in which H2S influences the epigenetic landscape and, subsequently, the progression of various neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's disease. H2S can modulate key components of the epigenetic machinery, such as DNA methylation, histone modifications, and non-coding RNAs, impacting gene expression and cellular functions relevant to neuronal survival, inflammation, and synaptic plasticity. We synthesize recent research that positions H2S as an essential player within this intricate network, with the potential to open new therapeutic avenues for these currently incurable conditions. Despite significant progress, there remains a considerable gap in our understanding of the precise molecular mechanisms and the potential therapeutic implications of modulating H2S levels or its downstream targets. We conclude by identifying future directions for research aimed at exploiting the therapeutic potential of H2S in neurodegenerative diseases.

Keywords: Alzheimer’s disease; DNA methylation; Huntington’s disease; Parkinson’s disease; epigenetic regulation; histone modifications; hydrogen sulfide; neurodegenerative diseases; non-coding RNAs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
This figure illustrates the central role of Hydrogen Sulfide (H2S) in epigenetic regulation and its interactions with various processes associated with neurodegenerative diseases. H2S affects epigenetic mechanisms, including histone modification, DNA methylation, and non-coding RNAs, which modulate gene expression and cellular functions relevant to neurodegeneration. H2S influences reactive oxygen species (ROS) production and oxidative stress levels, which play a critical role in the pathogenesis of neurodegenerative disorders. By reducing ROS production (blue arrow) and inhibiting ROS-generating processes at the mitochondrial level (red arrows), H2S impacts a broad spectrum of biological functions, as depicted in this figure for illustrative purposes. The interplay between H2S, epigenetic processes, and oxidative stress offers valuable insights into the molecular mechanisms underlying neurodegeneration and highlights the potential for therapeutic interventions to restore epigenetic balance and mitigate oxidative stress to combat neurodegenerative diseases effectively. The figure corroborates 3 major parts: 1. external sources and internal production of H2S; 2. the epigenetic role of H2S; and 3. the physiological connections presented in a simplified way.
Figure 2
Figure 2
Adapted PRISMA flow diagram, customized for our study.

Similar articles

Cited by

References

    1. Tello J.A., Williams H.E., Eppler R.M., Steinhilb M.L., Khanna M. Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery. Front. Mol. Neurosci. 2022;15:883358. doi: 10.3389/fnmol.2022.883358. - DOI - PMC - PubMed
    1. Akhtar A., Andleeb A., Waris T.S., Bazzar M., Moradi A.-R., Awan N.R., Yar M. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics. J. Control. Release. 2021;330:1152–1167. doi: 10.1016/j.jconrel.2020.11.021. - DOI - PubMed
    1. Wareham L.K., Liddelow S.A., Temple S., Benowitz L.I., Di Polo A., Wellington C., Goldberg J.L., He Z., Duan X., Bu G., et al. Solving neurodegeneration: Common mechanisms and strategies for new treatments. Mol. Neurodegener. 2022;17:23. doi: 10.1186/s13024-022-00524-0. - DOI - PMC - PubMed
    1. Guo J., Huang X., Dou L., Yan M., Shen T., Tang W., Li J. Aging and aging-related diseases: From molecular mechanisms to interventions and treatments. Signal Transduct. Target. Ther. 2022;7:391. doi: 10.1038/s41392-022-01251-0. - DOI - PMC - PubMed
    1. VandeVrede L., Boxer A.L., Polydoro M. Targeting tau: Clinical trials and novel therapeutic approaches. Neurosci. Lett. 2020;731:134919. doi: 10.1016/j.neulet.2020.134919. - DOI - PMC - PubMed

Publication types

Substances